- Remote BP monitoring works: Postpartum self-monitoring/telemanagement produced meaningful BP reductions (≈6–8 mm Hg), the only intervention with consistent benefit.
- Pharmacologic strategies lack evidence for long-term benefit: Antenatal and early postpartum drug/supplement interventions did not significantly lower BP in pooled analyses.
- Evidence gap is substantial: Most studies followed patients ≤2 weeks postpartum; robust long-term cardiovascular outcomes are largely absent.
- Surrogate improvements exist but are limited: Some studies show improved cardiac structure/function (e.g., diastolic function), but data are sparse and heterogeneous.
- Clinical implication: The peripartum period is a potential intervention window, but current practice should prioritize BP surveillance and follow-up, while awaiting higher-quality, long-term evidence.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
